Page last updated: 2024-12-05

nitrosobenzene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID11473
CHEMBL ID98797
CHEBI ID27986
SCHEMBL ID103117
MeSH IDM0059487

Synonyms (37)

Synonym
nitroso-benzene
CHEMBL98797 ,
CHEBI:27986 ,
benzene, nitroso-
nsc66479
nsc-66479
nsc 66479
einecs 209-591-1
inchi=1/c6h5no/c8-7-6-4-2-1-3-5-6/h1-5
nob ,
586-96-9
nitrosobenzene ,
C06876
nitrosobenzene, >=97%
AKOS000283822
FT-0653878
N0367
nitrosobenzene (substrate 1)
bdbm50065935
A831981
BMSE000925
zi9w9e8g2z ,
unii-zi9w9e8g2z
EPITOPE ID:115006
nitrosobenzene [mi]
SCHEMBL103117
keto-aniline
nitroso benzene
DTXSID7060417
mfcd00002059
SY031930
AMY2440
CS-11867
10.14272/NLRKCXQQSUWLCH-UHFFFAOYSA-N.1
doi:10.14272/nlrkcxqqsuwlch-uhfffaoysa-n.1
I10262
EN300-172931

Research Excerpts

Overview

Nitrosobenzene serves as a substrate for the enzyme and is converted faster than nitrobenzenes.

ExcerptReferenceRelevance
"Nitrosobenzene serves as a substrate for the enzyme and is converted faster than nitrobenzene."( Chemoselective nitro group reduction and reductive dechlorination initiate degradation of 2-chloro-5-nitrophenol by Ralstonia eutropha JMP134.
Knackmuss, HJ; Lenke, H; Schenzle, A; Spain, JC, 1999
)
1.02

Dosage Studied

ExcerptRelevanceReference
" If muscle tissue was dosed with nitrosobenzene and excised within 5 min, a similar three-line X-band EPR spectrum was obtained which was preceded by the rapid growth and subsequent decay of an EPR spectrum identical with that of the phenylhydronitroxide radical, which was presumably generated from reactions between nitrosobenzene and reducing agents in the blood or tissue such as NADH or ascorbic acid."( In vivo EPR studies of the metabolic fate of nitrosobenzene in the mouse.
Berliner, LJ; Fujii, H; Koscielniak, J; Zhao, B, 1994
)
0.83
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
xenobiotic metaboliteAny metabolite produced by metabolism of a xenobiotic compound.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
benzenesAny benzenoid aromatic compound consisting of the benzene skeleton and its substituted derivatives.
nitroso compoundCompounds having the nitroso group, -NO, attached to carbon, or to another element, most commonly nitrogen or oxygen.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
nitrobenzene degradation I18

Protein Targets (2)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Retinal dehydrogenase 1 Rattus norvegicus (Norway rat)IC50 (µMol)2.50002.50002.50002.5000AID34173
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (7)

Processvia Protein(s)Taxonomy
ubiquinone biosynthetic process1-deoxy-D-xylulose-5-phosphate synthaseEscherichia coli K-12
isoprenoid biosynthetic process1-deoxy-D-xylulose-5-phosphate synthaseEscherichia coli K-12
pyridoxine biosynthetic process1-deoxy-D-xylulose-5-phosphate synthaseEscherichia coli K-12
thiamine biosynthetic process1-deoxy-D-xylulose-5-phosphate synthaseEscherichia coli K-12
isopentenyl diphosphate biosynthetic process, methylerythritol 4-phosphate pathway1-deoxy-D-xylulose-5-phosphate synthaseEscherichia coli K-12
isoprenoid biosynthetic process1-deoxy-D-xylulose-5-phosphate synthaseEscherichia coli K-12
thiamine biosynthetic process1-deoxy-D-xylulose-5-phosphate synthaseEscherichia coli K-12
terpenoid biosynthetic process1-deoxy-D-xylulose-5-phosphate synthaseEscherichia coli K-12
1-deoxy-D-xylulose 5-phosphate biosynthetic process1-deoxy-D-xylulose-5-phosphate synthaseEscherichia coli K-12
isopentenyl diphosphate biosynthetic process, methylerythritol 4-phosphate pathway1-deoxy-D-xylulose-5-phosphate synthaseEscherichia coli K-12
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (7)

Processvia Protein(s)Taxonomy
magnesium ion binding1-deoxy-D-xylulose-5-phosphate synthaseEscherichia coli K-12
1-deoxy-D-xylulose-5-phosphate synthase activity1-deoxy-D-xylulose-5-phosphate synthaseEscherichia coli K-12
transferase activity1-deoxy-D-xylulose-5-phosphate synthaseEscherichia coli K-12
transketolase or transaldolase activity1-deoxy-D-xylulose-5-phosphate synthaseEscherichia coli K-12
thiamine pyrophosphate binding1-deoxy-D-xylulose-5-phosphate synthaseEscherichia coli K-12
protein homodimerization activity1-deoxy-D-xylulose-5-phosphate synthaseEscherichia coli K-12
metal ion binding1-deoxy-D-xylulose-5-phosphate synthaseEscherichia coli K-12
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (1)

Processvia Protein(s)Taxonomy
cytosol1-deoxy-D-xylulose-5-phosphate synthaseEscherichia coli K-12
cytosol1-deoxy-D-xylulose-5-phosphate synthaseEscherichia coli K-12
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (6)

Assay IDTitleYearJournalArticle
AID766211Binding affinity to rabbit muscle GAPDH peptide V232 to R245 assessed as formation of sulfinic acid and N-phenylsulfinamide by LC-MS analysis2013Journal of medicinal chemistry, Sep-12, Volume: 56, Issue:17
Direct and nitroxyl (HNO)-mediated reactions of acyloxy nitroso compounds with the thiol-containing proteins glyceraldehyde 3-phosphate dehydrogenase and alkyl hydroperoxide reductase subunit C.
AID766204Binding affinity to alkyl hydroperoxide reductase subunit C C165S mutant (unknown origin) assessed as formation of sulfinic acid by LC-MS analysis2013Journal of medicinal chemistry, Sep-12, Volume: 56, Issue:17
Direct and nitroxyl (HNO)-mediated reactions of acyloxy nitroso compounds with the thiol-containing proteins glyceraldehyde 3-phosphate dehydrogenase and alkyl hydroperoxide reductase subunit C.
AID34173Inhibitory activity against yeast aldehyde dehydrogenase (AIDH)1998Journal of medicinal chemistry, Jul-16, Volume: 41, Issue:15
Prodrugs of nitroxyl and nitrosobenzene as cascade latentiated inhibitors of aldehyde dehydrogenase.
AID766213Binding affinity to rabbit muscle GAPDH tryptic peptide I143 to K159 assessed as formation of disulfide bond by LC-MS analysis2013Journal of medicinal chemistry, Sep-12, Volume: 56, Issue:17
Direct and nitroxyl (HNO)-mediated reactions of acyloxy nitroso compounds with the thiol-containing proteins glyceraldehyde 3-phosphate dehydrogenase and alkyl hydroperoxide reductase subunit C.
AID23443Partition coefficient (logP)1985Journal of medicinal chemistry, Mar, Volume: 28, Issue:3
Use of physicochemical parameters in distance geometry and related three-dimensional quantitative structure-activity relationships: a demonstration using Escherichia coli dihydrofolate reductase inhibitors.
AID1800220DXP Synthase Inhibition Assay from Article 10.1002/cbic.201300187: \\DXP synthase-catalyzed C-N bond formation: nitroso substrate specificity studies guide selective inhibitor design.\\2013Chembiochem : a European journal of chemical biology, Jul-22, Volume: 14, Issue:11
DXP synthase-catalyzed C-N bond formation: nitroso substrate specificity studies guide selective inhibitor design.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (92)

TimeframeStudies, This Drug (%)All Drugs %
pre-199034 (36.96)18.7374
1990's13 (14.13)18.2507
2000's19 (20.65)29.6817
2010's24 (26.09)24.3611
2020's2 (2.17)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 49.78

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index49.78 (24.57)
Research Supply Index4.55 (2.92)
Research Growth Index4.51 (4.65)
Search Engine Demand Index73.87 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (49.78)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (2.13%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other92 (97.87%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]